Kim HJ - Search Results

1

Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder.

Kim W, Kim SH, Lee SH, Li XF, Kim HJ. Kim W, et al. Among authors: kim hj, kim sh. Mult Scler. 2011 Sep;17(9):1107-12. doi: 10.1177/1352458511404917. Epub 2011 May 4. Mult Scler. 2011. PMID: 21543554

2

Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica.

Kim HJ, Park HY, Kim E, Lee KS, Kim KK, Choi BO, Kim SM, Bae JS, Lee SO, Chun JY, Park TJ, Cheong HS, Jo I, Shin HD. Kim HJ, et al. Among authors: kim e, kim kk, kim sm. Neurobiol Dis. 2010 Feb;37(2):349-55. doi: 10.1016/j.nbd.2009.10.013. Epub 2009 Oct 20. Neurobiol Dis. 2010. PMID: 19850125

3

F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.

Kim SK, Im HJ, Kim W, Kim TS, Hwangbo B, Kim HJ. Kim SK, et al. Among authors: kim ts, kim w, kim hj. Clin Nucl Med. 2010 Feb;35(2):67-70. doi: 10.1097/RLU.0b013e3181c7c149. Clin Nucl Med. 2010. PMID: 20090446

4

Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity.

Kim W, Park MS, Lee SH, Kim SH, Jung IJ, Takahashi T, Misu T, Fujihara K, Kim HJ. Kim W, et al. Among authors: kim hj, kim sh. Mult Scler. 2010 Oct;16(10):1229-36. doi: 10.1177/1352458510376640. Epub 2010 Aug 4. Mult Scler. 2010. PMID: 20685766

5

Single-dose versus fractionated stereotactic radiotherapy for brain metastases.

Kim YJ, Cho KH, Kim JY, Lim YK, Min HS, Lee SH, Kim HJ, Gwak HS, Yoo H, Lee SH. Kim YJ, et al. Among authors: kim jy, kim hj. Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):483-9. doi: 10.1016/j.ijrobp.2010.05.033. Epub 2010 Aug 26. Int J Radiat Oncol Biol Phys. 2011. PMID: 20800386

6

Relapsing demyelinating CNS disease in a Korean pediatric population: multiple sclerosis versus neuromyelitis optica.

Lim BC, Hwang H, Kim KJ, Hwang YS, Cheon JE, Kim IO, Kim HJ, Chae JH. Lim BC, et al. Among authors: kim kj, kim hj, kim io. Mult Scler. 2011 Jan;17(1):67-73. doi: 10.1177/1352458510382685. Epub 2010 Sep 21. Mult Scler. 2011. PMID: 20858690

7

Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica.

Kim SH, Kim W, Park MS, Sohn EH, Li XF, Kim HJ. Kim SH, et al. Among authors: kim w, kim hj. Arch Neurol. 2011 Apr;68(4):473-9. doi: 10.1001/archneurol.2010.322. Epub 2010 Dec 13. Arch Neurol. 2011. PMID: 21149806

8

Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels.

Nakashima I, Takahashi T, Cree BA, Kim HJ, Suzuki C, Genain CP, Vincent T, Fujihara K, Itoyama Y, Bar-Or A. Nakashima I, et al. Among authors: kim hj. J Clin Neurosci. 2011 Jul;18(7):997-8. doi: 10.1016/j.jocn.2010.12.011. Epub 2011 May 11. J Clin Neurosci. 2011. PMID: 21565508

9

Curcumin protects against ovariectomy-induced bone loss and decreases osteoclastogenesis.

Kim WK, Ke K, Sul OJ, Kim HJ, Kim SH, Lee MH, Kim HJ, Kim SY, Chung HT, Choi HS. Kim WK, et al. Among authors: kim hj, kim sh, kim sy. J Cell Biochem. 2011 Nov;112(11):3159-66. doi: 10.1002/jcb.23242. J Cell Biochem. 2011. PMID: 21732406

10

Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years.

Kim SH, Kim W, Li XF, Jung IJ, Kim HJ. Kim SH, et al. Among authors: kim w, kim hj. Arch Neurol. 2011 Nov;68(11):1412-20. doi: 10.1001/archneurol.2011.154. Epub 2011 Jul 11. Arch Neurol. 2011. PMID: 21747007

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,956 results

Search Page